Previous 10 | Next 10 |
2024-04-18 02:47:32 ET More on Intra-Cellular Therapies Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data Intra-Cellular Therapies Is On Fire Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment I...
2024-04-16 17:02:18 ET Gainers: United Airlines Holdings ( UAL ) +6% . American Airlines Group ( AAL ) +2% . Enphase Energy ( ENPH ) +2% . Absci Corporation ( ABSI ) +1% . Ocular Therapeutix ( OCUL ) +1% . Losers: J.B. Hu...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...
2024-04-16 16:10:43 ET More on Intra-Cellular Therapies Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data Intra-Cellular Therapies Is On Fire Intra-Cellular files lawsuits challenging Caplyta generics Read the full article on Seeki...
2024-04-16 13:17:12 ET Summary Intra-Cellular Therapies, Inc. achieved positive results from Study 501, using lumateperone as an adjunctive therapy for the treatment of patients with MDD; Both primary and secondary endpoints achieved with statistical significance. The Major Depres...
2024-04-16 12:40:38 ET More on Mid-day movers & stocks. Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript Jaguar Health shareholders approve reverse stock split BioSig Technologies to reduce its internal workforce to cut down costs Seeking Alpha...
Shares of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) traded at a new 52-week high today and are currently trading at $80.66. So far today, approximately 2.54M shares have been exchanged, as compared to an average 30-day volume of 533.56k shares. Intra-Cellular Therapies, Inc., a biopharmac...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0.1629 on volume of 102,747,129 shares WiSA Technologies Inc. (WISA) rose 69.1% to $2.96 on volume of 24,734,833 shares Peraso Inc. (PRSO) rose 37.0% to $1.7393 on volume of 23,546,162 shares ...
2024-04-16 09:29:31 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- Palisade Bio, Inc. (Nasdaq: PALI ), Brera Holding (NASDAQ: BREA ), Peraso Inc. (NASDAQ: PRSO ), BioRestorative Therapies, Inc. (NASDAQ: BRTX ), and Intra-Cellular Ther...
2024-04-16 09:01:36 ET More on Intra-Cellular Therapies Intra-Cellular Therapies Is On Fire Intra-Cellular Therapies, Inc. (ITCI) Q4 2023 Earnings Call Transcript Intra-Cellular Therapies: Buoyant Caplyta Sales And Upcoming MDD Data Support Short-Term 'Buy' I...
News, Short Squeeze, Breakout and More Instantly...
Intra-Cellular Therapies Inc. Company Name:
ITCI Stock Symbol:
NASDAQ Market:
Intra-Cellular Therapies Inc. Website:
2024-06-20 15:00:05 ET Graig Suvannavejh from Mizuho Securities issued a price target of $100.00 for ITCI on 2024-06-20 12:10:00. The adjusted price target was set to $100.00. At the time of the announcement, ITCI was trading at $76.06. The overall price target consensus...
In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints Lumateperone 42 mg met the primary endpoint of change from baseline at Week 6 on the Montgomery- Åsberg Depression Rating Sc...
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Office...